(R)-N-Boc-2-Hydroxymethylmorpholine
Product Description
Hangzhou Fst Pharmaceutical Co.,Ltd
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:3
-
Employees:250 - 499
Company types
Primary activities
Categories
Specifications
Hangzhou Fst Pharmaceutical Co.,Ltd
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:3
-
Employees:250 - 499
Company types
Primary activities
More Products from Hangzhou Fst Pharmaceutical Co.,Ltd (2)
-
Product Eicosanedioic acid
Eicosanedioic acid is a building block for the synthesis of the GLP-1/GIP receptor dual agonist developed by Eli Lilly. This agonist can be used in the research of type 2 diabetes, diabetes-related neuropathy, and obesityIt is a non-cleavable ADC linker used for synthesizing antibody-drug conjugates (ADCs)... -
Product 3,6,12,15-Tetraoxa-9,18-diazatricosanedioic acid
The C20 fatty acid side chain is one of the key intermediates in the synthesis of the GLP-1/GIP receptor dual agonist developed by Eli Lilly, which can be used in the research of type 2 diabetes, diabetes-related neuropathy, and obesity
Hangzhou Fst Pharmaceutical Co.,Ltd resources (1)
-
Brochure Introduction
Established in 2002, Hangzhou FST Pharmaceutical focuses on advanced intermediates, APIs, and nutraceuticals. In 2022, it was acquired by Shanghai Eyougene Biotechnology, founded by top Fudan University graduates. Eyougene excels in digital CDMO services for advanced intermediates and new materials. The group has R&D centers in Shanghai, Xi'an, and Wuhan, with 382 employees, including 169 R&D and QA professionals. The main products include cardiovascular, gastrointestinal, and weight control products.
Located in Jiande Hangzhou, the factory complies with GMP and holds ISO9001:2000, ISO14001, and OHSAS18001 certifications. Eyougene is committed to life science innovation for human health.
Here is the profile of Eyougene and FST. You can find the introduction of company, technology, products,production system and business partners.